Value Propositions
In the meeting processing sector, animal blood, particularly in its coagulated form – remains largely underutilised and is predominantly discarded as waste, posing environmental issues. Teagasc researchers have developed a scalable and sustainable bioprocess that converts theses resources into high value bioactive peptides. In addition to a sustainable waste valorisation solution for meat processors, the realisation of new value added opportunities can create economic prosperity for food, nutraceutical, and cosmetics industries while improving health and wellbeing benefits downstream.
Opportunity
By upcycling slaughterhouse blood waste into bioactive peptides from renewable sources, commercialisation of this IP can have significant economic, environmental and health related impact.
Teagasc wishes to engage with the meat sector and broader industries – including sectors such as functional food/ beverage, cosmetic, animal nutrition to find the optimal route to commercialisation.
Development stage
- Successfully validated at laboratory scale, demonstrating technical feasibility and optimized process conditions.
- Advancing toward small-scale pilot development to confirm performance under operational conditions, with market-oriented trials planned.
Advantages
- A multi-step integrated process, delivering cost effective, high yield recovery of bioactive peptides from animal blood.
- Enables selective isolation of functional peptides with enhanced functional properties. Produces clean, stable bioactive ingredients for incorporation into high-value sectors such as functional foods, dietary supplements, cosmetics, and nutraceuticals.
Research Funding:
Department of Agriculture, Food and the Marine- 2023 Competitive Call (FIRM)
Project “Circular Bovine and Ovine Co-Products Valorisation-CirCoVal-Bovine R”
Teagasc PI: Brijesh Tiwari
